Piedmont Investment Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Piedmont Investment Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,517	Closed	-$533K	–	1387
2019 Q1	$533K	Buy	8,517 +598	+8%	+$41.1K	0.02%	503
2018 Q4	$473K	Buy	7,919 +388	+5%	+$23.3K	0.02%	480
2018 Q3	$485K	Buy	7,531 +248	+3%	+$13.8K	0.02%	530
2018 Q2	$328K	Buy	7,283 +678	+10%	+$27K	0.02%	598
2018 Q1	$205K	Buy	+6,605	New	+$217K	0.01%	705
2017 Q4	–	Sell	-6,696	Closed	-$221K	–	827
2017 Q3	$221K	Buy	6,696 +500	+8%	+$17.3K	﹤0.01%	691
2017 Q2	$207K	Buy	+6,196	New	+$185K	﹤0.01%	694

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Piedmont Investment Advisors's BEAT Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 8,517 shares — an estimated $533K sold.

Piedmont Investment Advisors first reported a position in BEAT in Q2 2017 and held it in 7 quarters. The position peaked at $533K in Q1 2019. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Piedmont Investment Advisors reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Piedmont Investment Advisors sold 8,517 BioTelemetry, Inc. shares in Q2 2019, an estimated $533K.
Piedmont Investment Advisors first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 7 quarters.
Piedmont Investment Advisors's BioTelemetry, Inc. position peaked at $533K in Q1 2019.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.